Mesothelin expression is associated with poor outcomes in breast cancer

BACKGROUND: Mesothelin, previously shown to be expressed in triple negative breast cancer (TNBC), is a potential therapeutic target and prognostic marker in breast cancer. METHODS: We analyzed clinical data from two cohorts comprising of 141 patients treated between 2009 and 2011 at our institution...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Breast Cancer Res Treat
Main Authors: Li, Yun R., Xian, Rena R., Ziober, Amy, Conejo-Garcia, Jose, Perales-Puchalt, Alfredo, June, Carl H., Zhang, Paul J., Tchou, Julia
Format: Artigo
Sprog:Inglês
Udgivet: 2014
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4261925/
https://ncbi.nlm.nih.gov/pubmed/25193277
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-014-3077-5
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker